SLGL Sol-Gel Technologies Ltd.
$68.18▼ -0.01%
Healthcare
Other
Volume 25.6K
Avg Volume (10D) 44.6K
Key Metrics & Fundamentals
Market Cap
$223.22M
P/E Ratio
–
Div Yield
0.00%
52W Range
28.81 - 97.97
% vs 50 MA
-1.81%
% vs 200 MA
-7.87%
RSI-14
48.4
MACD Histogram
+0.0500
Beta (1Y vs SPY)
0.86
Gross Rev
$591,000
Gross Profit
$591,000
EBITDA
-$4.16M
COGS
–
Operating Exp
$4.75M
Operating Income
-$4.16M
EBIT
-$4.16M
Pretax Income
-$3.68M
Net Income
-$3.68M
EPS (Diluted)
-1.13
Price & Volume History
Loading chart…
Recent News
New Strong Buy Stocks for October 16th
Zacks · Oct 16, 2026 3:04 AM ET
Sol-Gel Eyes 2028 Launch as SGT-610 Nears Pivotal Gorlin Syndrome Data
MarketBeat · Oct 14, 2026 11:02 PM ET
Cantor Fitzgerald Initiates Sol-Gel Technologies at Overweight Rating
MT Newswires · Oct 14, 2026 6:24 AM ET
SolGel Technologies (SLGL) Upgraded to Buy: Here's Why
Zacks · Oct 8, 2026 11:00 AM ET
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
GlobeNewswire · Sep 30, 2026 9:14 AM ET
SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks · Sep 17, 2026 9:55 AM ET
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
GlobeNewswire · Sep 17, 2026 8:30 AM ET
Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
GlobeNewswire · Aug 20, 2026 8:30 AM ET
Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 10, 2026 5:55 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SLGL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.